Twist Bioscience Corp
NASDAQ:TWST

Watchlist Manager
Twist Bioscience Corp Logo
Twist Bioscience Corp
NASDAQ:TWST
Watchlist
Price: 27.22 USD -1.8% Market Closed
Market Cap: 1.6B USD

Wall Street
Price Targets

TWST Price Targets Summary
Twist Bioscience Corp

Wall Street analysts forecast TWST stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TWST is 45.58 USD with a low forecast of 35.35 USD and a high forecast of 60.03 USD.

Lowest
Price Target
35.35 USD
30% Upside
Average
Price Target
45.58 USD
67% Upside
Highest
Price Target
60.03 USD
121% Upside
Twist Bioscience Corp Competitors:
Price Targets
VCEL
Vericel Corp
53% Upside
EXEL
Exelixis Inc
18% Upside
ACAD
ACADIA Pharmaceuticals Inc
18% Upside
CRVO
Diffusion Pharmaceuticals Inc
119% Upside
87S
Roivant Sciences Ltd
72% Upside
ADCT
ADC Therapeutics SA
165% Upside
196170
Alteogen Inc
13% Upside
096530
Seegene Inc
70% Upside

Revenue
Forecast

Revenue Estimate
Twist Bioscience Corp

For the last 7 years the compound annual growth rate for Twist Bioscience Corp's revenue is 62%. The projected CAGR for the next 3 years is 19%.

62%
Past Growth
19%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Twist Bioscience Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-8%
Average Miss

Net Income
Forecast

Net Income Estimate
Twist Bioscience Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-21%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is TWST's stock price target?
Price Target
45.58 USD

According to Wall Street analysts, the average 1-year price target for TWST is 45.58 USD with a low forecast of 35.35 USD and a high forecast of 60.03 USD.

What is Twist Bioscience Corp's Revenue forecast?
Projected CAGR
19%

For the last 7 years the compound annual growth rate for Twist Bioscience Corp's revenue is 62%. The projected CAGR for the next 3 years is 19%.

Back to Top